A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets

A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets

<b>Background:</b> HBV-specific T lymphocytes are pivotal in eliminating the hepatitis B virus (HBV) and regulating intrahepatic inflammatory reactions. Effective T cell responses curtail HBV infection; however, compromised immunity can result in persistent infection. Beyond the acute ph...

Full description

Bibliographic Details
Main Authors:	Daqiong Zhou, Lili Liu, Jiangyu Liu, Hong Li, Jing Zhang, Zhenhuan Cao
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Journal of Clinical Medicine
Subjects:	hepatitis B virus chronic HBV infection immune checkpoints inhibitory receptors T cell exhaustion
Online Access:	https://www.mdpi.com/2077-0383/13/5/1210

Similar Items

Recent Advances in HBV and HCV Immunology
by: Lynn B Dustin, et al.
Published: (2015-09-01)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
by: Ruben C. Hoogeveen, et al.
Published: (2020-03-01)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
by: Yeping Sun, et al.
Published: (2018-09-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Editorial: Inhibitory Receptors and Pathways of Lymphocytes
by: Alexandre M. Carmo, et al.
Published: (2020-07-01)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
by: Cesare Mazzaro, et al.
Published: (2022-10-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
by: Bei Jiang, et al.
Published: (2022-12-01)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
by: Haoyu Sun, et al.
Published: (2019-10-01)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
by: Xiaomei Wang, et al.
Published: (2021-01-01)

Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma
by: Ruonan Sun, et al.
Published: (2023-04-01)

Risk stratification of HBV infection in Asia-Pacific region
by: Jia-Horng Kao
Published: (2014-09-01)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
by: Yu-Chan Yang, et al.
Published: (2021-12-01)

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection
by: Sara Ferrando-Martinez, et al.
Published: (2021-09-01)

Hepatitis B Virus (HBV) Genotype Mixtures, Viral Load, and Liver Damage in HBV Patients Co-infected With Human Immunodeficiency Virus
by: Alexis Jose-Abrego, et al.
Published: (2021-03-01)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
by: Mary C. Kuhns, et al.
Published: (2021-10-01)

Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C
by: Valeria Barili, et al.
Published: (2021-09-01)

Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
by: Mariantonietta Di Stefano, et al.
Published: (2023-02-01)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
by: Chih-Wei Tseng, et al.
Published: (2022-04-01)

Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients
by: Lazarević Ivana, et al.
Published: (2014-01-01)

SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope
by: Yue Liu, et al.
Published: (2020-04-01)

High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable
by: Chengwei Wang, et al.
Published: (2023-05-01)

Treatment of patients with HBV cirrhosis: Successes, unsolved problems
by: I G Bakulin, et al.
Published: (2013-12-01)

Quantification of hepatitis B virus (HBV) DNA and HBV genotyping simultaneously in plasma using real-time polymerase chain reaction
by: Woottichai Khamduang, et al.
Published: (2018-08-01)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
by: Giuseppe Gentile, et al.
Published: (2019-11-01)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
by: Xin Liu, et al.
Published: (2023-08-01)

A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine
by: Yu-Min Choi, et al.
Published: (2023-06-01)

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
by: Valentina Svicher, et al.
Published: (2023-03-01)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
by: Si-Yu Yuan, et al.
Published: (2022-06-01)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
by: Senthil K. Chinnakannan, et al.
Published: (2020-04-01)

A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model
by: Yunlong Hu, et al.
Published: (2020-03-01)

HBV Infection in HIV-Driven Immune Suppression
by: Loredana Sarmati, et al.
Published: (2019-11-01)

The Progress of Anti-HBV Constituents from Medicinal Plants in China
by: Chang-An Geng, et al.
Published: (2018-07-01)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas<sup>®</sup> HBV Test for Use on the Cobas<sup>®</sup> 4800 System
by: Valérie Ortonne, et al.
Published: (2021-03-01)

Anti-HBV Drugs: Progress, Unmet Needs, and New Hope
by: Lei Kang, et al.
Published: (2015-09-01)

HBV in Italian Women’s Jail: An Underestimated Problem?
by: Nicholas Geremia, et al.
Published: (2024-02-01)

Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country
by: Erwin Ho, et al.
Published: (2024-03-01)

T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis
by: Juliana C. Costa-Madeira, et al.
Published: (2022-05-01)

Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study
by: Qian Yang, et al.
Published: (2024-03-01)